Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission. (7th November 2013) - Goh, J; Mason, J; Chan, J; Moradi, M; Berek, J; Beningno, B; Mileshkin, L; Recio, F; Tchabo, N; Rossi, E; Eisenberg, P; Rose, P; et al.